Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
Nobel Chemistry prize going to CRISPR scientists
By Christine Filippis / October 9, 2020
Genetic scissors: a tool for rewriting the code of life wins the 2020 Nobel Prize for Chemistry Emmanuelle Charpentier and...
Read More
Good news from Cartherics. The company’s off-the-shelf immune therapy for ovarian cancer is close to clinical trials
By Christine Filippis / September 23, 2020
View the article in the CRC (Cooperative Research Centres Association) Association Newsletter here : CRC Association Newsletter Cartherics’ cost-effective ‘off-the-shelf’...
Read More
Frustrated by Victoria’s COVID-19 Lockdown? Try India ……
By Christine Filippis / September 22, 2020
That’s where Anisha Balachandran - Cartherics’ past PhD student has been since January 22 September 2020 Finally, Anisha is back,...
Read More
